Predictors of in-hospital mortality in patients with successful primary coronary intervention for acute ST-elevation myocardial infarction presenting as cardiogenic shock

Acta Cardiologica Sinica

Volumn 26, Issue 2, 2010, Pages 81-88

  Yang, Shao Chi ^a   Wang, Yi Chih ^a   Hwang, Juey Jen ^a   Hsu, Kwan Lih ^a   Chiang, Fu Tien ^a   Tseng, Chuen Den ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acute myocardial infarction; Cardiogenic shock; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; TICLOPIDINE;

ACUTE HEART INFARCTION; AGED; AORTA BALLOON; ARTICLE; CARDIOGENIC SHOCK; CAUSE OF DEATH; CONTINUOUS INFUSION; CORONARY ARTERY BLOOD FLOW; CORONARY STENT; CREATININE BLOOD LEVEL; EXTRACORPOREAL OXYGENATION; FEMALE; HOSPITALIZATION; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LEUKOCYTE COUNT; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTOR VARIABLE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 77955906227     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Califf RM, Bengtson JR. Cardiogenic shock. N Engl J Med 1994;330:1724-30.
2. Goldberg RJ, Gore JM, Alpert JS, et al. Cardiogenic shock after acute myocardial infarction: incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med 1991;325:1117-22.
3. Holmes DRJ, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries. JAm Coll Cardiol 1995;26:668-74.
4. Apolito RA, Greenberg MA, Menegus MA, et al. Impact of the New York State Cardiac Surgery and Percutaneous Coronary Intervention Reporting System on the management of patients with acute myocardial infarction complicated by cardiogenic shock. Am Heart J 2008;155:267-73
5. Fang J, Mensah GA, Alderman MH, Croft CB. Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States. Am Heart J 2006;152:1035-41.
6. Hochman JS, Sleeper LA, White HD, et al. One-year survival following early revascularization for cardiogenic shock. JAMA 2001;285:190-2.
7. Sleeper LA, Ramanathan K, Picard MH, et al. Functional capacity and quality of life following emergency revascularization for cardiogenic shock complicating acute myocardial infarction. JAm Coll Cardiol 2005;46:266-73. (Pubitemid 40966854)
8. Hibbard MD, Holmes DR Jr, Bailey KR. Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock. J Am Coll Cardiol 1992;19:639-46.
9. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization and long-termsurvival in cardiogenic shock complicating acute myocardial infarction. JAMA 2006;295:2511-5.
10. Barry WL, Sarembock IJ. Cardiogenic shock: therapy and prevention. Clin Cardiol 1998;21:72-80.
11. Antoniucci D, Valenti R, Santoro GM. Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival. J Am Coll Cardiol 1998;31:294-300. (Pubitemid 28153446)
12. White HD, Palmeri ST, Sleeper LA, et al. Electrocardiographic findings in cardiogenic shock, risk prediction, and the effects of emergency revascularization: results from the SHOCK trial. Am Heart J 2004;148:810-7.
13. Klein LW, Shaw RE, Krone RJ, et al. Mortality after Emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model. Am J Cardiol 2005;96:35-41. (Pubitemid 40853936)
14. Sutton AGC, Finn P, Hall JA, et al. Predictors of outcome after percutaneous treatment for cardiogenic shock. Heart 2005;91:339-44. (Pubitemid 40299215)
15. Sabatine MS, Morrow DA, Cannon CP, et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy - Thrombolysis in Myocardial Infarction 18 trial) substudy. J Am Coll Cardiol 2002;40:1761-8.
16. Smit JJ, Ottervanger JP, Slingerland RJ, et al. Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction. Am J Cardiol 2008;101:446-51.
17. Suryapranata H, van't Hof AW, Hoorntje JC. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998;73:2502-5.
18. Marenzi G, Moltrasio M, Assanelli E, et al. Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty. Am Heart J 2007;153:755-62. (Pubitemid 46602147)
19. Gibson CM, Pinto DS, Murphy SA, et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol 2003;42:1535-43.
20. Yamaguchi J, Kasanuki H, Ishii Y, et al. Prognostic significance of serum creatinine concentration for in-hospital mortality in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] registry). Am J Cardiol 2004;93:1526-8. (Pubitemid 38749211)
21. Sianos G, Morel MA, Kappetein AP, et al. The Syntax score: an angiographic tool grading the complexity of coronary artery disease. Eurointervention 2005;1:219-227.